A carregar...
Immune Checkpoint Inhibitors as Monotherapy or Within a Combinatorial Strategy in Advanced Hepatocellular Carcinoma
In advanced-stage hepatocellular carcinoma (HCC), systemic treatment represents the standard therapy. Target therapy has marked a new era based on a greater knowledge of molecular disease signaling. Nonetheless, survival outcomes and long-term response remain unsatisfactory, mostly because of the on...
Na minha lista:
Main Authors: | , |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
MDPI AG
2020-08-01
|
Colecção: | International Journal of Molecular Sciences |
Assuntos: | |
Acesso em linha: | https://www.mdpi.com/1422-0067/21/17/6302 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|